Similar Articles

Alternative electric tumor treatment areas in glioblastoma multiforme treatment: Rationale, preclinical and clinical studies

Ayşe Uyanık, Yusuf Bahap, Alpcan Ateş, Elif Özge Doğan, Oytun Erbaş

DOI: 10.5606/fng.btd.2017.027

Issue: 2017, Volume 3 - Issue 4
0 4331

Current trends in Glioblastoma

Mihrican Koçak, Özüm Atasoy, Nilsu Çini, Oytun Erbaş

DOI: 10.5606/fng.btd.2021.25074

Issue: 2021, Volume 7 - Issue 3
8784 2153

Glioblastoma multiforme: Subtypes based on IDH, ATRX, H3F3A, MGMT and p53 mutations

Fatime Akgeyik, Alper Demirezen, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.144

Issue: 2024, Volume 10 - Issue 1
7088 2307

Genetically engineered mice models and generating glioblastoma multiforme in the brain

Yasin Polat, Oytun Erbaş

DOI: 10.5606/fng.btd.2024.147

Issue: 2024, Volume 10 - Issue 1
3988 2570

Ferroptosis-related gene regulation and miRNA/lncRNA Network on Temozolomide Resistance in Glioblastoma

Ece Gumusoglu-Acar, Tuba Gunel

DOI: 10.5606/fng.btd.2025.210

Issue: 2025, Volume 11 - Issue 3
1319 873